Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Intranasal Ketamine (IN) for Depression
Recruiting1 award4 criteria
Toronto, Ontario
This trial aims to study the effects of intranasal ketamine on patients with ultra-resistant depression, who have not responded to other treatments.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.